Neovii
Marta Gonzàlez is an accomplished professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as General Manager for Spain and Portugal at Neovii since October 2021, as well as Iberia Business Development Director, Marta has demonstrated strong leadership and business development skills. Previous roles include Rare Diseases Key Account Manager and Scientific & Market Access Manager at EUSA Pharma, as well as Senior Medical Science Liaison at Jazz Pharmaceuticals. Marta began their career at Pfizer, where responsibilities included managing key customer relationships in rare tumors. An alumnus of Universitat de Barcelona with a degree in Biological Sciences and EADA Business School with a postgraduate in Market Access, Marta excels in building relationships with key opinion leaders and navigating complex healthcare landscapes.
This person is not in any teams
This person is not in any offices
Neovii
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.